Callan Family Office LLC Takes Position in Xylem Inc. $XYL

Callan Family Office LLC acquired a new stake in Xylem Inc. (NYSE:XYL) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,323 shares of the industrial products company’s stock, valued at approximately $629,000.

Other hedge funds also recently added to or reduced their stakes in the company. Orion Porfolio Solutions LLC increased its position in Xylem by 1.0% during the 3rd quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock valued at $1,151,000 after purchasing an additional 74 shares during the period. Quest Investment Management LLC lifted its position in shares of Xylem by 1.0% in the 3rd quarter. Quest Investment Management LLC now owns 7,588 shares of the industrial products company’s stock worth $1,119,000 after purchasing an additional 77 shares during the period. Notis McConarty Edward boosted its stake in shares of Xylem by 0.3% during the fourth quarter. Notis McConarty Edward now owns 31,678 shares of the industrial products company’s stock valued at $4,314,000 after purchasing an additional 86 shares in the last quarter. Moneco Advisors LLC boosted its stake in shares of Xylem by 4.6% during the fourth quarter. Moneco Advisors LLC now owns 2,049 shares of the industrial products company’s stock valued at $279,000 after purchasing an additional 90 shares in the last quarter. Finally, Compound Planning Inc. increased its holdings in Xylem by 4.2% during the fourth quarter. Compound Planning Inc. now owns 2,258 shares of the industrial products company’s stock valued at $308,000 after buying an additional 91 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Price Performance

Shares of XYL opened at $112.76 on Wednesday. The company has a market cap of $26.33 billion, a price-to-earnings ratio of 26.85, a price-to-earnings-growth ratio of 1.58 and a beta of 1.02. Xylem Inc. has a twelve month low of $105.29 and a twelve month high of $154.27. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23. The company has a 50 day moving average of $118.11 and a two-hundred day moving average of $119.31.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.34 by $0.12. The business had revenue of $2.34 billion for the quarter, compared to the consensus estimate of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The business’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.26 earnings per share. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, analysts predict that Xylem Inc. will post 5.66 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 24th. Investors of record on Thursday, August 27th will be given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend is Thursday, August 27th. Xylem’s dividend payout ratio is currently 40.95%.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Royal Bank Of Canada upped their target price on Xylem from $159.00 to $164.00 and gave the stock an “outperform” rating in a report on Wednesday, July 29th. Robert W. Baird lifted their price target on Xylem from $163.00 to $165.00 and gave the company an “outperform” rating in a report on Wednesday, July 29th. Citigroup reissued a “buy” rating on shares of Xylem in a research report on Wednesday, July 29th. Weiss Ratings restated a “hold (c)” rating on shares of Xylem in a research note on Wednesday, August 5th. Finally, Oppenheimer dropped their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 29th. Nine research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $155.00.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.